Domov › Metastatski rak › Ohio › Columbus
Klinične študije za Metastatski rak v Columbus, OH
27 študij za Metastatski rak išče udeležence na lokacijah v Columbus in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Vključevanje udeležencevFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- in še 13
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Vključevanje udeležencevFaza 1
- Ohio State University Comprehensive Cancer Center, Columbus
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Vključevanje udeležencevFaza 1
- ALX Center 10, Columbus
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Vključevanje udeležencevFaza 2/3
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Vključevanje udeležencevFaza 1/2
- Ohio State University, Columbus
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Vključevanje udeležencevFaza 3
- The Mark H Zangmeister Center, Columbus
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Hilliard · 10 mi stran
SLV-154 Treatment of Advanced Cancers
Vključevanje udeležencevFaza 1
- The James Outpatient Care West Center, Columbus
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Vključevanje udeležencevFaza 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Clinical Study Site, Columbus
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Ohio State University Hospital, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Vključevanje udeležencevFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Vključevanje udeležencevFaza 2
- Ohio State University, Columbus
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Vključevanje udeležencevFaza 1
- The Ohio State University (OSU), Columbus
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Vključevanje udeležencevFaza 1
- Ohio State University Comprehensive Cancer Center, Columbus
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Vključevanje udeležencevFaza 3
- Research Site, Columbus
- Research Site, Hilliard · 10 mi stran
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Vključevanje udeležencevFaza 1
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of LY4175408 in Participants With Advanced Cancer
Vključevanje udeležencevFaza 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Vključevanje udeležencevFaza 1/2
- OSU Brain & Spine Hospital, Columbus
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Vključevanje udeležencevFaza 3
- Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Vključevanje udeležencevFaza 3
- Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Vključevanje udeležencevFaza 2/3
- The Ohio State University, Columbus
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Vključevanje udeležencevFaza 1
- OSU Brain and Spine Hospital, Columbus
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Vključevanje udeležencevFaza 3
- The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Columbus
Študije za Metastatski rak v drugih mestih
- Houston, TX104 študij
- New York City, NY93 študij
- Nashville, TN70 študij
- Boston, MA63 študij
- Los Angeles, CA57 študij
- St. Louis, MO54 študij
- Arlington, VA53 študij
- Philadelphia, PA46 študij
- Chicago, IL45 študij
- San Antonio, TX44 študij
- Washington, DC43 študij
- Dallas, TX42 študij
Druge študije v Columbus
- Nemalicelični pljučni rak57 študij
- Rak dojke40 študij
- Rak jajčnikov39 študij
- Rak (vse vrste)38 študij
- Rak pljuč37 študij
- Akutna mieločna levkemija35 študij
- Kronična limfocitna levkemija28 študij
- Rak endometrija25 študij
- Rak prostate24 študij
- Množni mielom24 študij
- Kolorektalni rak24 študij
- Melanom21 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.